HealthDay – MONDAY, June 29 (HealthDay News) — Treatment with interferon gamma-1b
(Ifn-g1b) does not improve survival in people with a fatal lung disease
called idiopathic pulmonary fibrosis, according to a study that was halted
early after no benefit to participants was found.
Read full article…

Other Headlines

• Iron Overload: Treatment For Common Genetic Disorder
• The Wall Street Journal — now for ‘professionals’
• How you like me now?!
• Dust-up over healthcare reform ahead of Senate panel’s vote
• Food Companies Guilty Of Misleading People With Health Claims, Says Which?
• Grayson sweet-talks Republicans on healthcare reform
• U.N. says millions still lack access to AIDS drugs (Reuters)